scholarly journals Ethical and Legal Aspects of Using the Abortion Pill RU-486 in Italy in the Years 2020-2021

2021 ◽  
Vol 47 (3) ◽  
pp. 174-186
Author(s):  
Andrzej Kobyliński

In some countries, one of the most difficult bioethical challenges of the SARS-CoV-2 coronavirus pandemic has been a sharp rise in the number of chemical abortions performed in hospitals, outpatient clinics, or at home. Limited access to medical services at public and private healthcare facilities and the development of telemedicine have resulted in the practice of chemical abortion having largely moved from hospitals and clinics to the home. Chemical abortion is a method used only in the early stages of pregnancy, i.e. up to 7-9 weeks. The first stage of abortion involves taking RU-486, a pill containing a preparation called Mifepristone which kills the newly conceived life in the mother’s womb. The second stage of chemical abortion involves the use of a preparation called Misoprostol, which leads to the expulsion of the dead embryo from the woman’s body. The main goal of the article is to analyze the ethical and legal dispute in Italy in the years 2020 and 2021 concerning new ways of using the abortion pill RU-486. In August 2020, the Italian Ministry of Health decided that chemical abortion – performed using the medical preparation RU-486 – should not be practiced at hospital gynecological and obstetric wards, but in day hospitals, without the requirement of hospitalization for women performing such abortions. Analyses carried out in the article show that chemical abortion not only kills the life of a human embryo, but in some cases may also be dangerous to the life and health of the mother. The liberalization of chemical abortion in Italy has led to an increase in the number of unborn children who are aborted, as it facilitates access to this type of abortion and makes it a procedure that is largely self-administered at home. The Italian dispute over home abortion and the RU-486 pill is linked to other serious bioethical debates that are currently taking place in many countries around the world

Author(s):  
Nikita V. Polukhin ◽  
Natalia V. Ekkert ◽  
Mikhail V. Vodolagin

Aims: To evaluate the Russian Federation healthcare providers’ websites compliance to legal requirements on availability of patient-oriented medicines supply information and compare the evaluation results between public and private healthcare facilities. Study Design: Cross-sectional study. Place and Duration of Study: The evaluation of compliance to legal requirements to medicines supply information on public and private healthcare providers’ websites available on the Internet was conducted in September 2021. Methodology: The study included a simple random sample of 66 websites of Russian healthcare providers containing two groups:  public (n=33) and private (n=33) healthcare facilities’ websites. The compliance evaluation was performed by checking the availability of 4 medicines lists on the websites: (1) essential medicines list; (2) list of medicines for the most expensive chronic diseases to treat; (3) list of medicines that are prescribed only by shared decision of healthcare facility medical commission; (4) list of medicines that are dispensed for certain social groups with no charge or with 50% discount in outpatient care settings. Results: The difference of availability of the first list was 90.9% (95% CI 77.7%–97.4%) vs. 33.3% (95% CI 19.2%–50.3%) on public and private healthcare facilities’ website, respectively, P<.001. The difference of that in the second list was 42.4% (95% CI 26.8%–59.3%) vs. 15.2% (95% CI 6.0%–30.1%), P<.028. For the third no statistical significance was revealed (P>.05). For the fourth list the difference was 66.7% (95% CI 49.7%–80.8%) vs. 21.2% (95% CI 10.0%–37.2%), P<.001. Conclusion: It is required to improve the supervision approaches for both public and private healthcare facilities for better patient-oriented medicines supply information provision. The problem may be solved by the implementation of a centralized government policy repository with regularly updated lists, requirements, and best practices.


Author(s):  
Mohamed Izham Mohamed Ibrahim ◽  
Mohammed Alshakka ◽  
Nazeh Al-abd ◽  
Awsan Bahattab ◽  
Wafa Badulla

Background: Medicine and medical supplies are often in short supply in countries suffering from the scourge of conflict. Effective medicine supply policies are lacking in many low- and middle-income countries (LMICs), particularly during conflict. This study aimed to assess the availability of essential medicines in both the public and private healthcare sectors. Methods: The study was conducted by administering a survey from November 2017 to February 2018 using the World Health Organization/Health Action International (WHO/HAI) guidelines and methodology. Thirty healthcare facilities in thirteen districts from three governorates in Yemen were included in the assessment of thirty essential medicines. The results were reported as frequencies and percentages of outlets with available medicines on the day of data collection. Results: A set of 30 vital and essential medicines were selected from the list of essential medicines that are used in healthcare centers in Yemen to treat prevalent diseases. In general, only 52.8% of the selected medicines were available in public and private healthcare settings. The distribution and availability of medicines in the three governorates were approximately equal. The availability of medicines was better in the private healthcare settings, specifically 73.3% in private hospitals and approximately 79.7% in private pharmacies. Conclusions: The availability of essential medicines during this state of conflict in three governorates in Yemen is low, in both public and private hospitals and healthcare centers. Many of the medications that were not available are used to treat chronic illnesses.


2021 ◽  
Vol 2 (3) ◽  
pp. 32-38
Author(s):  
I.P. Mazur ◽  
O.M. Vakhnenko ◽  
A.V. Rybachuk ◽  
P.V. Mazur

The article presents an analysis of the results of state and sectoral statistical reports of dental healthcare institutions, which were submitted to the State Institution “Center for Medical Statistics of the Ministry of Health of Ukraine” in 2020. As of January 1, 2021, 22,180 general dental practitioners and 766 dentists provided dental care to the population of Ukraine in 6,443 institutions of various forms of ownership. The article pre-sents the structure, staffing level and dentistry personnel density in Ukraine; also, a comparative analysis for the last 5 years was conducted in terms of staffing level of dentists working in healthcare institutions of different forms of ownership. The main indicators of the system of providing dental care in both public and private healthcare facilities are presented. A comparative analysis with the main indicators of dental care for 2019 was carried out. The number of routine examinations of the oral cavity decreases and the number of malignant neoplasms, especially advanced ones, increases.


2003 ◽  
Vol 23 (6) ◽  
pp. 417-419 ◽  
Author(s):  
Khalid M. Alaiban ◽  
Badran Al-Omar ◽  
Lutchmie Narine ◽  
A. F. Al-Assaf ◽  
Fatima Javed

Geographies ◽  
2021 ◽  
Vol 1 (1) ◽  
pp. 47-62
Author(s):  
Ujjwal Das ◽  
Barkha Chaplot ◽  
Hazi Mohammad Azamathulla

Skilled birth attendance and institutional delivery have been advocated for reducing maternal, neonatal mortality and infant mortality (NMR and IMR). This paper examines the role of place of delivery with respect to neo-natal and infant mortality in India using four rounds of the Indian National Family Health Survey conducted in 2015–2016. The place of birth has been categorized as “at home” or “public and private institution.” The role of place of delivery on neo-natal and infant mortality was examined by using multivariate hazard regression models adjusted for clus-tering and relevant maternal, socio-economic, pregnancy and new-born characteristics. There were 141,028 deliveries recorded in public institutions and 54,338 in private institutions. The esti-mated neonatal mortality rate in public and private institutions during this period was 27 and 26 per 1000 live births respectively. The study shows that when the mother delivers child at home, the chances of neonatal mortality risks are higher than the mortality among children born at the health facility centers. Regression analysis also indicates that a professionally qualified provider′s antenatal treatment and assistance greatly decreases the risks of neonatal mortality. The results of the study illustrate the importance of the provision of institutional facilities and proper pregnancy in the prevention of neonatal and infant deaths. To improve the quality of care during and imme-diately after delivery in health facilities, particularly in public hospitals and in rural areas, accel-erated strengthening is required.


Author(s):  
Jennifer L. Cadnum ◽  
Basya S. Pearlmutter ◽  
Annette L. Jencson ◽  
Hanan Haydar ◽  
Michelle T. Hecker ◽  
...  

Abstract Objective: To investigate the frequency of environmental contamination in hospital areas outside patient rooms and in outpatient healthcare facilities. Design: Culture survey. Setting: This study was conducted across 4 hospitals, 4 outpatient clinics, and 1 surgery center. Methods: We conducted 3 point-prevalence culture surveys for methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, Clostridioides difficile, Candida spp, and gram-negative bacilli including Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter baumanii, and Stenotrophomonas maltophilia in each facility. In hospitals, high-touch surfaces were sampled from radiology, physical therapy, and mobile equipment and in emergency departments, waiting rooms, clinics, and endoscopy facilities. In outpatient facilities, surfaces were sampled in exam rooms including patient and provider areas, patient bathrooms, and waiting rooms and from portable equipment. Fluorescent markers were placed on high-touch surfaces and removal was assessed 1 day later. Results: In the hospitals, 110 (9.4%) of 1,195 sites were positive for 1 or more bacterial pathogens (range, 5.3%–13.7% for the 4 hospitals) and 70 (5.9%) were positive for Candida spp (range, 3.7%–5.9%). In outpatient facilities, 31 of 485 (6.4%) sites were positive for 1 or more bacterial pathogens (range, 2% to 14.4% for the 5 outpatient facilities) and 50 (10.3%) were positive for Candida spp (range, 3.9%–23.3%). Fluorescent markers had been removed from 33% of sites in hospitals (range, 28.4%–39.7%) and 46.3% of sites in outpatient clinics (range, 7.4%–82.8%). Conclusions: Surfaces in hospitals outside patient rooms and in outpatient facilities are frequently contaminated with healthcare-associated pathogens. Improvements in cleaning and disinfection practices are needed to reduce contamination.


Author(s):  
Ching Siang Tan ◽  
Saim Lokman ◽  
Yao Rao ◽  
Szu Hua Kok ◽  
Long Chiau Ming

AbstractOver the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this COVID-19 pandemic. The resurgence of COVID-19 cases has overwhelmed the public healthcare system and overloaded the healthcare resources. Ministry of Health (MOH) Malaysia has adopted an Emergency Ordinance (EO) to instruct private hospitals to receive both COVID-19 and non-COVID-19 patients to reduce the strain on public facilities. The treatment of COVID-19 patients at private hospitals could help to boost the bed and critical care occupancy. However, with the absence of insurance coverage because COVID-19 is categorised as pandemic-related diseases, there are some challenges and opportunities posed by the treatment fees management. Another major issue in the collaboration between public and private hospitals is the willingness of private medical consultants to participate in the management of COVID-19 patients, because medical consultants in private hospitals in Malaysia are not hospital employees, but what are termed “private contractors” who provide patient care services to the hospitals. Other collaborative measures with private healthcare providers, e.g. tele-conferencing by private medical clinics to monitor COVID-19 patients and the rollout of national vaccination programme. The public and private healthcare partnership must be enhanced, and continue to find effective ways to collaborate further to combat the pandemic. The MOH, private healthcare sectors and insurance providers need to have a synergistic COVID-19 treatment plans to ensure public as well as insurance policy holders have equal opportunities for COVID-19 screening tests, vaccinations and treatment.


Sign in / Sign up

Export Citation Format

Share Document